The Vanguard Group 13D and 13G filings for Enanta Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:04 pm Purchase |
2023-12-29 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
The Vanguard Group | 1,793,786 8.520% |
271,597 (+17.84%) |
Filing |
| 2023-02-09 11:19 am Sale |
2022-12-30 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
The Vanguard Group | 1,522,189 7.320% |
-103,720 (-6.38%) |
Filing |
| 2022-02-10 08:11 am Sale |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
The Vanguard Group | 1,625,909 8.000% |
-174,670 (-9.70%) |
Filing |
| 2021-02-10 10:52 am Purchase |
2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
The Vanguard Group | 1,800,579 8.970% |
102,850 (+6.06%) |
Filing |